BML Inc.
Financial Results Presentation for
the First Half of Fiscal 2021
November 11, 2021
Kensuke Kondo,
President and
Representative Director
Overview of the First Half of Fiscal 2021
2
First-Half Earnings History in 10 Years
Increase in tests related to COVID-19
(Millions of yen)
FY2021
1H
3
Year-on-Year Comparison
(Millions of yen)
FY2020 | FY2021 | YoY | Change | |
1H | 1H | |||
Net sales | 59,828 | 95,700 | 35,871 | 60.0% |
Testing business | 57,023 | 92,729 | 35,705 | 62.6% |
Clinical testing business | 55,226 | 90,695 | 35,469 | 64.2% |
Other testing business | 1,796 | 2,033 | 236 | 13.2% |
Medical informatics | 2,100 | 2,231 | 131 | 6.3% |
business | ||||
Other businesses | 705 | 739 | 34 | 4.9% |
Operating income | 4,973 | 27,525 | 22,552 | 453.4% |
Ordinary income | 5,275 | 28,433 | 23,158 | 439.0% |
Profit attributable to owners of | 3,514 | 18,761 | 15,246 | 433.8% |
parent | ||||
4
Breakdown of Changes in Sales by Business Segment
Net sales up ¥35,871m (60.0%) YoY
(Millions of yen)
+236 | +167 |
Food hygiene | Medical |
business, etc. | informatics |
business, | |
+35,469 | other businesses |
Clinical testing | |
business |
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
BML Inc. published this content on 11 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 November 2021 04:10:02 UTC.